Sunshine Guojian Pharmaceutical(Shanghai) Co.Ltd(688336) Pharmaceutical (Shanghai) Co., Ltd
Special statement of independent directors on external guarantee
As an independent director of Sunshine Guojian Pharmaceutical(Shanghai) Co.Ltd(688336) Pharmaceutical (Shanghai) Co., Ltd. (hereinafter referred to as the “company”) in accordance with the relevant provisions of the guidelines for the supervision of listed companies No. 8 – regulatory requirements for capital exchanges and external guarantees of listed companies and the guidelines for the self discipline supervision of listed companies on the science and Innovation Board of Shanghai Stock Exchange No. 1 – standardized operation of China Securities Regulatory Commission, We have carefully checked the external guarantee of the company in 2021 and made the following special instructions:
In 2021, the company did not have any external guarantee in any form, nor did it have any external guarantee in previous years but continued until 2021, and there was no situation damaging the interests of the company and all shareholders, especially minority shareholders.
Independent directors: Jin Yongli, Zhang Wei, Huang Rui March 28, 2022 (there is no text below, which is the signature page)
